Bond.az White LogoBond.az Black Logo

Guggenheim reiterates Buy rating on Okta stock

Guggenheim reiterates Buy rating on Okta stock with $138 price target. Analysts expect Q1 earnings to beat consensus.

Michael Brown
ByMichael Brown- Senior Editor
|
0

Guggenheim has reiterated a Buy rating and $138.00 price target on Okta (NASDAQ:OKTA) ahead of its Q1 fiscal 2027 earnings report on May 28, 2026.

The firm expects Okta to beat consensus estimates for Q1 revenue, including both subscription and total revenue. However, risks exist for Q2 revenue guidance if business momentum doesn't improve.

Okta shares currently trade at $85.70. Bond.az analysis suggests the stock is undervalued. The company maintains a strong gross profit margin of 77%. EPS forecast for fiscal 2027 is $3.96.

Guggenheim believes Okta's 9% year-over-year revenue growth guidance is achievable. The company could raise guidance by at least the amount of the Q1 beat.

Field checks showed improvement: out of five partners, two exceeded plan, two met plan, and one fell short. Pipelines were similarly split.

Federal new annual contract value contribution was about $6 million in Q1, less than 10% of total annual contract value.

Recently, several analysts including Cantor Fitzgerald, KeyBanc, Barclays, Raymond James, and BMO Capital have issued positive ratings on Okta.

More News
Today / 12:11
|
261

BMO Raises Israel Chemicals Target Price on Potash

BMO Capital raises Israel Chemicals price target to $6.50 on strong potash outlook and higher EBITDA guidance.

0
Today / 12:10
|
222

Cantor Fitzgerald raises PANW price target to $285

Cantor Fitzgerald raises Palo Alto Networks price target to $285, citing platformization, AI tailwinds, and strong partner results.

0
Today / 11:53
|
435

Stifel Maintains Manhattan Associates Price Target

Stifel maintains Buy rating and $200 target for Manhattan Associates. The company is investing in cloud migration and agentic AI capabilities.

0
Today / 11:52
|
256

Rosenblatt Raises 8x8 Target to $3.00

Rosenblatt raises 8x8 stock target to $3.00 after strong Q4 results. Revenue beat guidance.

0
Today / 11:52
|
385

Piper Sandler Reiterates Alphabet Overweight on AI

Piper Sandler reiterates Alphabet Overweight rating and $425 target after Google I/O AI product launches.

0
Today / 11:51
|
464

Rosenblatt Cuts Canaan Target Price to $1.30

Rosenblatt cuts Canaan stock price target to $1.30 from $2.25, maintains Buy rating. Canaan faces revenue miss in Q1 FY2026.

0
Today / 11:50
|
872

Bernstein raises Dell target to $280 on AI

Bernstein raises Dell price target to $280, citing agentic AI demand and SMCI share losses.

0
Today / 11:43
|
228

Alpha Tau Stock Gets Buy Rating, $15 Target

H.C. Wainwright reiterates Buy on Alpha Tau stock with $15 target. Company completes ReSTART trial enrollment.

0
Today / 11:42
|
472

H.C. Wainwright Reiterates Protara Buy Rating

H.C. Wainwright reiterates Buy rating on Protara Therapeutics (TARA) with $27 target. Encouraging results from lymphatic malformation and bladder cancer trials.

0
Today / 11:41
|
612

H.C. Wainwright reiterates MindWalk stock rating on platform validation

H.C. Wainwright reiterates Buy rating and $5 target on MindWalk stock, citing platform validation and strong pipeline. Read more.

0
Today / 11:40
|
376

Traws Pharma Gets $8 Price Target from H.C. Wainwright

H.C. Wainwright reaffirms Buy on Traws Pharma with $8 target. Financing secured for influenza drug trial. Read more on Bond.az.

0
Today / 11:33
|
665

Morgan Stanley raises ZTO target to $30.10

Morgan Stanley raises ZTO Express price target to $30.10 from $28.50, maintains Overweight rating, citing profit growth outlook.

0
...
Guggenheim reiterates Buy rating on Okta stock | Bond.az